Ionis Pharmaceuticals, Inc.

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -4.03%124.420.0%$2636.09m
BNGOBioNano Genomics, Inc. 15.30%9.720.0%$1943.24m
GILDGilead Sciences, Inc. 6.08%67.181.0%$664.89m
CRSPCRISPR Therapeutics AG -0.79%198.300.6%$578.41m
AMGNAmgen, Inc. 0.94%247.801.3%$557.42m
NVAXNovavax, Inc. 3.81%132.2892.9%$486.63m
REGNRegeneron Pharmaceuticals, Inc. 2.87%532.782.7%$470.74m
ALXNAlexion Pharmaceuticals, Inc. 1.42%158.932.0%$463.97m
ILMNIllumina, Inc. 2.45%385.553.5%$368.01m
BIIBBiogen, Inc. 0.96%278.501.7%$338.21m
SRPTSarepta Therapeutics, Inc. 4.04%93.9713.8%$331.34m
VRTXVertex Pharmaceuticals, Inc. 0.40%226.441.9%$328.99m
OCGNOcugen, Inc. 6.36%2.360.0%$324.74m
BNTXBioNTech SE 0.64%102.240.0%$316.48m
PACBPacific Biosciences of California, Inc. 3.43%38.197.4%$264.22m

Company Profile

Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The Akcea Therapeutics segment develops and commercializes drugs for cardiometabolic diseases. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli and Brett P. Monia in 1989 and is headquartered in Carlsbad, CA.